• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Polygenic Score for Body Mass Index Is Associated with Weight Loss and Lipid Outcomes After Metabolic and Bariatric Surgery.体重指数的多基因评分与代谢和减重手术后的体重减轻及脂质指标相关。
Int J Mol Sci. 2025 Jul 29;26(15):7337. doi: 10.3390/ijms26157337.
2
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
3
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.替尔泊肽10毫克和15毫克与司美格鲁肽2.4毫克治疗2型糖尿病患者肥胖和超重的间接比较疗效与安全性
Diabetes Obes Metab. 2025 Jun 19. doi: 10.1111/dom.16508.
4
Surgery for weight loss in adults.成人减肥手术。
Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.
5
The trend of atherogenic indices in patients with type 2 diabetes after bariatric surgery: a national cohort study.减重手术后2型糖尿病患者动脉粥样硬化指数的变化趋势:一项全国队列研究
Surg Obes Relat Dis. 2025 Apr;21(4):423-433. doi: 10.1016/j.soard.2024.10.022. Epub 2024 Oct 30.
6
Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature.减重手术后的长期结果:可调胃束带术 15 年随访结果及减重手术文献的系统评价
Ann Surg. 2013 Jan;257(1):87-94. doi: 10.1097/SLA.0b013e31827b6c02.
7
Optimizing Bariatric Surgery Outcomes: The Dual Benefits of Preoperative Very-Low-Calorie Diets.优化减肥手术效果:术前极低热量饮食的双重益处。
Obes Surg. 2025 Jul 22. doi: 10.1007/s11695-025-07996-1.
8
Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy for diabetes: predictors of remission and metabolic outcomes in a multicenter study.单吻合十二指肠-回肠旁路术联合袖状胃切除术治疗糖尿病:一项多中心研究中缓解及代谢结果的预测因素
Surg Obes Relat Dis. 2025 Aug;21(8):883-891. doi: 10.1016/j.soard.2025.03.007. Epub 2025 Apr 3.
9
Effectiveness of robotic metabolic and bariatric surgery in patients with BMI ≥ 50-59.9 and BMI ≥ 60 for the treatment of severe obesity in a national medical center in Mexico.墨西哥国家医疗中心对 BMI≥50-59.9 和 BMI≥60 的重度肥胖患者进行机器人代谢和减重手术的疗效。
J Robot Surg. 2024 Oct 26;18(1):382. doi: 10.1007/s11701-024-02138-8.
10
Genetic risk score based on obesity-related genes and progression in weight loss after bariatric surgery: a 60-month follow-up study.基于肥胖相关基因的遗传风险评分与减重手术后体重减轻进展:一项 60 个月随访研究。
Surg Obes Relat Dis. 2024 Sep;20(9):814-821. doi: 10.1016/j.soard.2024.04.002. Epub 2024 Apr 6.

本文引用的文献

1
Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery.可能的遗传因素与GLP-1受体激动剂和减肥手术导致的体重减轻之间的关联。
Nat Med. 2025 Apr 18. doi: 10.1038/s41591-025-03645-3.
2
Dietary Habits, Obesity, and Bariatric Surgery: A Review of Impact and Interventions.饮食习惯、肥胖与减肥手术:影响与干预综述
Nutrients. 2025 Jan 28;17(3):474. doi: 10.3390/nu17030474.
3
Use of polygenic risk scores to assess weight loss after bariatric surgery: a 5-year follow-up study.使用多基因风险评分评估减重手术后的体重减轻:一项 5 年随访研究。
J Gastrointest Surg. 2024 Sep;28(9):1400-1405. doi: 10.1016/j.gassur.2024.05.029. Epub 2024 May 29.
4
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study.5 年随访结果:一种吻合口胃旁路术与 Roux-en-Y 胃旁路术的疗效和安全性比较(YOMEGA):一项前瞻性、开放标签、非劣效性、随机扩展研究。
Lancet Diabetes Endocrinol. 2024 Apr;12(4):267-276. doi: 10.1016/S2213-8587(24)00035-4. Epub 2024 Mar 4.
5
Obesity management: sex-specific considerations.肥胖管理:针对不同性别的考量
Arch Gynecol Obstet. 2024 May;309(5):1745-1752. doi: 10.1007/s00404-023-07367-0. Epub 2024 Feb 8.
6
Recent advances in bariatric surgery: a narrative review of weight loss procedures.减肥手术的最新进展:减肥手术的叙述性综述
Ann Med Surg (Lond). 2023 Nov 1;85(12):6091-6104. doi: 10.1097/MS9.0000000000001472. eCollection 2023 Dec.
7
Obesity: A Review of Pathophysiology and Classification.肥胖症:病理生理学与分类综述。
Mayo Clin Proc. 2023 Dec;98(12):1842-1857. doi: 10.1016/j.mayocp.2023.05.026. Epub 2023 Oct 11.
8
Exploring the Genetic Association between Obesity and Serum Lipid Levels Using Bivariate Methods.利用双变量方法探索肥胖与血清脂质水平的遗传关联。
Twin Res Hum Genet. 2022 Dec;25(6):234-244. doi: 10.1017/thg.2022.39. Epub 2023 Jan 6.
9
Sex difference in the safety and efficacy of bariatric procedures: a systematic review and meta-analysis.减重手术安全性和疗效的性别差异:系统评价和荟萃分析。
Surg Obes Relat Dis. 2022 Jul;18(7):983-996. doi: 10.1016/j.soard.2022.03.022. Epub 2022 Apr 20.
10
The genetics of obesity: from discovery to biology.肥胖的遗传学:从发现到生物学。
Nat Rev Genet. 2022 Feb;23(2):120-133. doi: 10.1038/s41576-021-00414-z. Epub 2021 Sep 23.

体重指数的多基因评分与代谢和减重手术后的体重减轻及脂质指标相关。

Polygenic Score for Body Mass Index Is Associated with Weight Loss and Lipid Outcomes After Metabolic and Bariatric Surgery.

作者信息

Aldegheri Luana, Cipullo Chiara, Rosso Natalia, Catamo Eulalia, Casagranda Biagio, Giraudi Pablo, de Manzini Nicolò, Palmisano Silvia, Robino Antonietta

机构信息

Institute for Maternal and Child Health-IRCCS Burlo Garofolo, 34137 Trieste, Italy.

Metabolic Liver Disease Unit, Fondazione Italiana Fegato-ONLUS, Area Science Park, Basovizza, 34149 Trieste, Italy.

出版信息

Int J Mol Sci. 2025 Jul 29;26(15):7337. doi: 10.3390/ijms26157337.

DOI:10.3390/ijms26157337
PMID:40806468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12347326/
Abstract

Metabolic and bariatric surgery (MBS) is an effective treatment for severe obesity, though individual responses vary widely, partly due to genetic predisposition. This study investigates the association of a body mass index (BMI) polygenic score (PGS) with weight loss and metabolic outcomes following surgery. A cohort of 225 patients undergoing MBS was analyzed at baseline (T), six (T), and twelve (T) months, with anthropometric and biochemical parameters recorded at each time point. Total weight loss (TWL) and excess weight loss (EWL) percentages were calculated. PGS was computed using the LDpred-grid Bayesian method. The mean age was 45.9 ± 9.4 years. Males had a higher baseline prevalence of type 2 diabetes (T2D) and comorbidities ( < 0.001). Linear regression analysis confirmed an association between PGS and baseline BMI ( = 0.012). Moreover, mediation analysis revealed that baseline BMI mediated the effect of the PGS on %TWL at T, with an indirect effect (-value = 0.018). In contrast, high-density lipoprotein-cholesterol (HDL-C) at T and triglycerides (TG) at T showed direct associations with the PGS (-value = 0.004 and -value = 0.08, respectively), with no significant mediation by BMI. This study showed a BMI-mediated association of PGS with %TWL and a direct association with lipid changes, suggesting its potential integration into personalized obesity treatment.

摘要

代谢与减重手术(MBS)是治疗重度肥胖的有效方法,尽管个体反应差异很大,部分原因是遗传易感性。本研究调查了体重指数(BMI)多基因评分(PGS)与手术后体重减轻和代谢结果之间的关联。对225例接受MBS的患者队列在基线(T0)、6个月(T6)和12个月(T12)时进行分析,在每个时间点记录人体测量和生化参数。计算总体重减轻(TWL)和超重减轻(EWL)百分比。使用LDpred-grid贝叶斯方法计算PGS。平均年龄为45.9±9.4岁。男性2型糖尿病(T2D)和合并症的基线患病率更高(P<0.001)。线性回归分析证实PGS与基线BMI之间存在关联(P = 0.012)。此外,中介分析显示基线BMI介导了PGS对T0时TWL百分比的影响,间接效应显著(P值 = 0.018)。相比之下,T0时的高密度脂蛋白胆固醇(HDL-C)和T12时的甘油三酯(TG)与PGS呈直接关联(P值分别为0.004和0.08),BMI无显著中介作用。本研究表明PGS与TWL百分比之间存在BMI介导的关联,与脂质变化存在直接关联,表明其有可能整合到个性化肥胖治疗中。